{
    "id": "0903",
    "question": "A 54-year-old man comes to the clinic for management of his gastroesophageal reflux disease (GERD). He is currently on cimetidine for his condition and reports that his GERD initially improved. However, following his recent move to Michigan, he is experiencing more frequent episodes of chest pain (4-5 times a week). The pain is described as burning in quality and is concentrated around his epigastric region following food ingestion. It does not radiate anywhere and is alleviated when he takes antacids. A physical examination demonstrates a healthy male with unremarkable findings. He is subsequently prescribed a new medication for control of his symptoms. What is the most likely mechanism of action of this new medication?",
    "options": {
        "A": "Irreversible inactivation of cyclooxygenase enzyme",
        "B": "Irreversible inhibition of H+/K+-ATPase at parietal cells",
        "C": "Reversible inhibition of H+/K+-ATPase at parietal cells",
        "D": "Reversible inhibition of histamine H2 receptors"
    },
    "answer": "B",
    "predict": "Here is the step-by-step thinking and the answer in JSON format: {\"step_by_step_thinking\": \"The patient is experiencing worsening GERD symptoms, specifically burning chest pain in the epigastric region after food ingestion, which is relieved by antacids. The patient is already taking cimetidine, which is an H2 receptor antagonist. However, the new medication prescribed should have a different mechanism of action to address the worsening symptoms. The options provided are: A. Irreversible inactivation of cyclooxygenase enzyme, B. Irreversible inhibition of H+/K+-ATPase at parietal cells, C. Reversible inhibition of H+/K+-ATPase at parietal cells, D. Reversible inhibition of histamine H2 receptors. To address worsening GERD symptoms, the new medication should target the acid production in the stomach. The H+/K+-ATPase (proton pump) is the enzyme responsible for acid production in the stomach. Inhibiting this enzyme will reduce acid production, alleviating symptoms of GERD. Options B and C are correct in that they both describe the inhibition of H+/K+-ATPase at parietal cells. However, option C is reversible, whereas option B is irreversible, which is more effective for long-term management of GERD. Option D is incorrect as it targets histamine H2 receptors, which are involved in acid secretion but not the primary target for GERD treatment. Therefore, the most likely mechanism of action of the new medication is reversible inhibition of H+/K+-ATPase at parietal cells, which will provide long-term relief for the patient's worsening GERD symptoms.\", \"answer_choice\": \"C\"}",
    "snippets": [
        {
            "id": "Pharmacology_Katzung_3943",
            "title": "Pharmacology_Katzung",
            "content": "Ahmed A. Negm, MD, & Daniel E. Furst, MD twice daily. His symptoms are reduced at this dosage, but he com-plains of significant heartburn that is not controlled by antacids. He is then switched to celecoxib, 200 mg twice daily, and on this regimen his joint symptoms and heartburn resolve. Two years later, he returns with increased joint symptoms. His hands, wrists, elbows, feet, and knees are all now involved and appear swollen, warm, and tender. What therapeutic options should be considered at this time? What are the possible complications? A 48-year-old man presents with complaints of bilateral morning stiffness in his wrists and knees and pain in these joints on exercise. On physical examination, the joints are slightly swollen. The rest of the examination is unremarkable. His laboratory findings are also negative except for slight anemia, elevated erythrocyte sedi-mentation rate, and positive rheumatoid factor. With the diagnosis of rheumatoid arthritis, he is started on a regimen"
        },
        {
            "id": "InternalMed_Harrison_3045",
            "title": "InternalMed_Harrison",
            "content": "APPROACH TO THE PATIENT: PART 2 Cardinal Manifestations and Presentation of Diseases Care of the indigestion patient requires a thorough interview. GERD classically produces heartburn, a substernal warmth that moves toward the neck. Heartburn often is exacerbated by meals and may awaken the patient. Associated symptoms include regurgitation of acid or nonacidic fluid and water brash, the reflex release of salty salivary secretions into the mouth. Atypical symptoms include pharyngitis, asthma, cough, bronchitis, hoarseness, and chest pain that mimics angina. Some patients with acid reflux on esophageal pH testing do not report heartburn, but note abdominal pain or other symptoms."
        },
        {
            "id": "InternalMed_Harrison_22531",
            "title": "InternalMed_Harrison",
            "content": "Epigastric pain described as a burning or gnawing discomfort can be present in both DU and GU. The discomfort is also described as an ill-defined, aching sensation or as hunger pain. The typical pain pattern in DU occurs 90 minutes to 3 hours after a meal and is frequently relieved by antacids or food. Pain that awakes the patient from sleep (between midnight and 3 A.M.) is the most discriminating symptom, with two-thirds of DU patients describing this complaint. Unfortunately, this symptom is also present in one-third of patients with NUD (see below). Elderly patients are less likely to have abdominal pain as a manifestation of PUD and may instead present with a complication such as ulcer bleeding or perforation. The pain pattern in GU patients may be different from that in DU patients, where discomfort may actually be precipitated by food. Nausea and weight loss occur more commonly in GU patients. Endoscopy detects ulcers in <30% of patients who have dyspepsia."
        },
        {
            "id": "InternalMed_Harrison_22382",
            "title": "InternalMed_Harrison",
            "content": "Heartburn (pyrosis), the most common esophageal symptom, is characterized by a discomfort or burning sensation behind the sternum that arises from the epigastrium and may radiate toward the neck. Heartburn is an intermittent symptom, most commonly experienced after eating, during exercise, and while lying recumbent. The discomfort is relieved with drinking water or antacid but can occur frequently interfering with normal activities including sleep. The association between heartburn and gastroesophageal reflux disease (GERD) is so strong that empirical therapy for GERD has become accepted management. However, the term \u201cheartburn\u201d is often misused and/or referred to with other terms such as \u201cindigestion\u201d or \u201crepeating,\u201d making it important to clarify the intended meaning."
        },
        {
            "id": "Surgery_Schwartz_6883",
            "title": "Surgery_Schwartz",
            "content": "any therapy, particularly any form of esopha-geal surgery. The presence and severity of both typical symp-toms of heartburn, regurgitation, and dysphagia, and atypical symptoms of cough, hoarseness, chest pain, asthma, and aspira-tion should be discussed with the patient in detail. Many of these atypical symptoms may not be esophageal related and hence will not improve and may even worsen with antireflux surgery.Heartburn is generally defined as a substernal burning-type discomfort, beginning in the epigastrium and radiating upward. It is often aggravated by meals, spicy or fatty foods, chocolate, alcohol, and coffee and can be worse in the supine position. It is commonly, although not universally, relieved by antacid or antisecretory medications. Epidemiologic studies have shown that heartburn occurs monthly in as many as 40% Table 25-4American Gastroenterologic Association Gallup poll on nighttime gastroesophageal reflux disease symptoms\u2022 50 million Americans have nighttime"
        },
        {
            "id": "Surgery_Schwartz_7408",
            "title": "Surgery_Schwartz",
            "content": "reflux disease (GERD), helicobacter gastritis, and other disorders of the stomach, gallbladder, and pancreas. Although none of the aforementioned symptoms alone is specific for gastric disease, when elicited in the con-text of a careful history and physical examination, they point to a differential diagnosis, which can be refined with certain tests. Early endoscopy should be considered in patients present-ing with recent onset of alarm symptoms (weight loss, anemia, dysphagia, vomiting) particularly those over 55 years of age (Table 26-5).Diagnostic TestsEsophagogastroduodenoscopy. Esophagogastroduodenos-copy (EGD) is a safe and accurate outpatient procedure per-formed under conscious sedation.64 Smaller flexible scopes with excellent optics and a working channel are easily passed trans-nasally in the unsedated patient. Following an 8-hour fast, the flexible scope is advanced under direct vision into the esopha-gus, stomach, and duodenum. The fundus and GE junction are inspected by"
        },
        {
            "id": "InternalMed_Harrison_1315",
            "title": "InternalMed_Harrison",
            "content": "PART 2 Cardinal Manifestations and Presentation of Diseases Gastrointenstinal Esophageal reflux 10\u201360 min Burning Substernal, epigastric Worsened by postprandial recumbency; relieved by antacids Esophageal spasm 2\u201330 min Pressure, tightness, Retrosternal Can closely mimic angina burning Peptic ulcer Prolonged; 60\u201390 min Burning Epigastric, substernal Relieved with food or antacids after meals Gallbladder disease Prolonged Aching or colicky Epigastric, right upper May follow meal quadrant; sometimes to the back Neuromuscular Costochondritis Variable Aching Sternal Sometimes swollen, tender, warm over joint; may be reproduced by localized pressure on examination Trauma or strain Usually constant Aching Localized to area of Reproduced by movement or strain palpation Herpes zoster Usually prolonged Sharp or burning Dermatomal distribution Vesicular rash in area of discomfort"
        },
        {
            "id": "Pediatrics_Nelson_2763",
            "title": "Pediatrics_Nelson",
            "content": "Typical symptoms are listed in Table 128-3. The presenceof recurrent burning epigastric and retrosternal pain is arisk factor for esophagitis. With duodenal ulcers, pain typically occurs several hours after meals and often awakenspatients at night. Eating tends to relieve the pain. Gastriculcers differ in that pain is commonly aggravated by eating, Table 128-3 Peptic Disorders, Symptoms, and Clinical Investigation SYNDROME AND ASSOCIATED SYMPTOMS CLINICAL INVESTIGATION ESOPHAGITIS Retrosternal and epigastric Endoscopy location Therapeutic trial of acid-blocker Burning pain therapy Sensation of regurgitation pH probe study Dysphagia, odynophagia Upper abdominal location Endoscopy Fullness Therapeutic trial of acid-blocker Bloating therapy Nausea Upper GI series to ligament of"
        },
        {
            "id": "InternalMed_Harrison_22439",
            "title": "InternalMed_Harrison",
            "content": "Heartburn and regurgitation are the typical symptoms of GERD. Somewhat less common are dysphagia and chest pain. In each case, multiple potential mechanisms for symptom genesis operate that extend beyond the basic concepts of mucosal erosion and activation of afferent sensory nerves. Specifically, hypersensitivity and functional pain are increasingly recognized as cofactors. Nonetheless, the dominant clinical strategy is empirical treatment with acid inhibitors, reserving further evaluation for those who fail to respond. Important exceptions to this are patients with chest pain or persistent dysphagia, each of which may be indicative of more morbid conditions. With chest pain, cardiac disease must be carefully considered. In the case of persistent dysphagia, chronic reflux can lead to the development of copy with mucosal biopsies, which are necessary tion. In terms of endoscopic appearance, infectious esophagitis is diffuse and tends to involve the proximal esophagus far more"
        },
        {
            "id": "Pharmacology_Katzung_4939",
            "title": "Pharmacology_Katzung",
            "content": "A 45-year-old man is brought to the local hospital emer-gency department by ambulance. His wife reports that he had been in his normal state of health until 3 days ago when he developed a fever and a productive cough. Dur-ing the last 24 hours he has complained of a headache and is increasingly confused. His wife reports that his medical history is significant only for hypertension, for which he takes hydrochlorothiazide and lisinopril, and that he is allergic to amoxicillin. She says that he developed a rash many years ago when prescribed amoxicillin for bron-chitis. In the emergency department, the man is febrile (38.7\u00b0C [101.7\u00b0F]), hypotensive (90/54 mmHg), tachypneic (36/min), and tachycardic (110/min). He has no signs of meningismus but is oriented only to person. A stat chest x-ray shows a left lower lung consolidation consistent with pneumonia. A CT scan is not concerning for lesions or elevated intracranial pressure. The plan is to start empiric antibiotics and perform a"
        },
        {
            "id": "InternalMed_Harrison_22346",
            "title": "InternalMed_Harrison",
            "content": "When classic symptoms of gastroesophageal reflux are present, such as water brash and substernal heartburn, presumptive diagnosis and empirical treatment are often sufficient. Endoscopy is a sensitive test for diagnosis of esophagitis (Fig. 345-38), but will miss nonerosive reflux disease (NERD) because some patients have symptomatic reflux without esophagitis. The most sensitive test for diagnosis of GERD is 24-h ambulatory pH monitoring. Endoscopy is indicated in patients with reflux symptoms refractory to antisecretory therapy; in those with alarm symptoms, such as dysphagia, weight loss, or gastrointestinal bleeding; and in those with recurrent dyspepsia after treatment that is not clearly due to reflux on clinical grounds alone. Endoscopy should be considered in patients with long-standing (\u226510 years) GERD, because they have a sixfold increased risk of harboring Barrett\u2019s esophagus compared to a patient with <1 year of reflux symptoms. Patients with Barrett\u2019s esophagus (Fig."
        },
        {
            "id": "InternalMed_Harrison_3048",
            "title": "InternalMed_Harrison",
            "content": "Once alarm factors are excluded (Table 54-3), patients with typi cal GERD do not need further evaluation and are treated empiri cally. Upper endoscopy is indicated to exclude mucosal injury in cases with atypical symptoms, symptoms unresponsive to acid sup pression, or alarm factors. For heartburn >5 years in duration, espe cially in patients >50 years old, endoscopy is advocated to screen for Barrett\u2019s metaplasia. The benefits and cost-effectiveness of this approach have not been validated in controlled studies. Ambulatory endoscopically attached to the esophageal wall is considered for chest pain. High-resolution esophageal manometry is ordered when surgical treatment of GERD is considered. A low LES pressure predicts failure of drug therapy and provides a rationale to proceed to surgery. Poor esophageal body peristalsis raises concern about postoperative dysphagia and directs the choice of surgical tech nique. Nonacidic reflux may be detected by combined esophageal impedance-pH"
        },
        {
            "id": "Pharmacology_Katzung_1490",
            "title": "Pharmacology_Katzung",
            "content": "Ramin Sam, MD, Harlan E. Ives, MD, PhD, & David Pearce, MD A 65-year-old man has a history of diabetes and chronic kidney disease with baseline creatinine of 2.2 mg/dL. Despite five different antihypertensive drugs, his clinic blood pres-sure is 176/92 mm Hg; he has mild dyspnea on exertion and 2\u20133+ edema on exam. He has been taking furosemide 80 mg twice a day for 1 year now. At the clinic visit, hydrochlorothi-azide 25 mg daily is added for better blood pressure control and also to treat symptoms and signs of fluid overload. Two weeks later, the patient presents to the emergency depart-ment with symptoms of weakness, anorexia, and generalized malaise. His blood pressure is now 91/58 mm Hg, and he has lost 15 kg in 2 weeks. His laboratory tests are signifi-cant for a serum creatinine of 10.8 mg/dL. What has led to the acute kidney injury? What is the reason for the weight loss? What precautions could have been taken to avoid this hospitalization?"
        },
        {
            "id": "InternalMed_Harrison_3039",
            "title": "InternalMed_Harrison",
            "content": "DIFFERENTIAL DIAgNOSIS gastroesophageal Reflux Disease Gastroesophageal reflux disease (GERD) is prevalent. Heartburn is reported once monthly by 40% of Americans and daily by 7\u201310%. Most cases of heartburn occur because of excess acid reflux, but reflux of nonacidic fluid produces similar symptoms. Alkaline reflux esophagitis produces GERD-like symptoms most often in patients who have had surgery for peptic ulcer disease. Ten percent of patients with heartburn exhibit normal esophageal acid exposure and no increase in nonacidic reflux (functional heartburn)."
        },
        {
            "id": "Pharmacology_Katzung_5216",
            "title": "Pharmacology_Katzung",
            "content": "Camille E. Beauduy, PharmD, & Lisa G. Winston, MD* A 60-year-old man presents to the emergency department with a 2-month history of fatigue, weight loss (10 kg), fevers, night sweats, and a productive cough. He is currently living with friends and has been intermittently homeless, spending time in shelters. He reports drinking about 6 beers per day. In the emergency department, a chest x-ray shows a right apical infiltrate. Given the high suspicion for pulmonary tuberculosis, the patient is placed in respiratory isolation. His first sputum smear shows many acid-fast bacilli, and an HIV test returns with a positive result. What drugs should be started for treatment of presumptive pulmonary tubercu-losis? Does the patient have a heightened risk of developing medication toxicity? If so, which medication(s) would be likely to cause toxicity?"
        },
        {
            "id": "InternalMed_Harrison_22381",
            "title": "InternalMed_Harrison",
            "content": "The clinical history remains central to the evaluation of esophageal symptoms. A thoughtfully obtained history will often expedite management. Important details include weight gain or loss, gastrointestinal bleeding, dietary habits including the timing of meals, smoking, and alcohol consumption. The major esophageal symptoms are heartburn, regurgitation, chest pain, dysphagia, odynophagia, and globus sensation."
        },
        {
            "id": "First_Aid_Step2_273",
            "title": "First_Aid_Step2",
            "content": "Symptomatic re\ufb02ux of gastric contents into the esophagus, most commonly as a result of transient LES relaxation. Can be due to an incompetent LES, gastroparesis, or hiatal hernia. Patients present with heartburn that commonly occurs 30\u201390 minutes after a meal, worsens with reclining, and often improves with antacids, sitting, or standing. Substernal chest pain can be difficult to distinguish from other causes. Sour taste (\u201cwater brash\u201d), globus, unexplained cough, and morning hoarseness can be clues. Exam is usually normal unless a systemic disease (e.g., scleroderma) is present. The history and clinical impression are important. An empiric trial of lifestyle modification and medical treatment is often attempted first. Studies may include barium swallow (to look for hiatal hernia), esophageal manometry, and 24-hour pH monitoring. Squamous cell esophageal cancer is associated with tobacco and alcohol use."
        },
        {
            "id": "Pharmacology_Katzung_2968",
            "title": "Pharmacology_Katzung",
            "content": "A 76-year-old retired banker complains of a shuffling gait with occasional falls over the last year. He has developed a stooped posture, drags his left leg when walking, and is unsteady on turning. He remains independent in all activi-ties of daily living, but he has become more forgetful and occasionally sees his long-deceased father in his bedroom. Examination reveals hypomimia, hypophonia, a slight rest tremor of the right hand and chin, mild rigidity, and impaired rapid alternating movements in all limbs. Neuro-logic and general examinations are otherwise normal. What is the likely diagnosis and prognosis? The patient is started on a dopamine agonist, and the dose is gradually built up to the therapeutic range. Was this a good choice of medications? Six months later, the patient and his wife return for follow-up. It now becomes apparent that he is falling asleep at inappropriate times, such as at the dinner table, and when awake, he spends much of the time in arranging and"
        },
        {
            "id": "InternalMed_Harrison_22472",
            "title": "InternalMed_Harrison",
            "content": "Typical symptoms of pill esophagitis are the sudden onset of chest pain and odynophagia. Characteristically, the pain will develop over a period of hours or will awaken the individual from sleep. A classic history in the setting of ingestion of recognized pill offenders obviates the need for diagnostic testing in most patients. When endoscopy is performed, localized ulceration or inflammation is evident. Histologically, acute inflammation is typical. Chest CT imaging will sometimes reveal esophageal thickening consistent with transmural inflammation. Although the condition usually resolves within days to weeks, symptoms may persist for months and stricture can develop in severe cases. No specific therapy is known to hasten the healing process, but antisecretory medications are frequently prescribed to remove concomitant reflux as an aggravating factor. When healing results in stricture formation, dilation is indicated."
        },
        {
            "id": "Pharmacology_Katzung_5286",
            "title": "Pharmacology_Katzung",
            "content": "Harry W. Lampiris, MD, & Daniel S. Maddix, Pharm D The patient is a 37-year-old African-American man who lives in San Jose, California. He was recently incarcerated near Bakersfield, California and returned to Oakland about 3 months ago. He is currently experiencing one month of severe headache and double vision. He has a temperature of 38.6\u00b0C (101.5\u00b0F) and the physical exam reveals nuchal rigidity and right-sided sixth cranial nerve palsy. MRI of his brain is normal, and lumbar puncture reveals 330 WBC with 20% eosinophils, protein 75, and glucose 20. HIV test is negative, TB skin test is negative, CSF cryptococcal antigen is negative, and CSF gram stain is negative. Patient receives empiric therapy for bacterial meningitis with van-comycin and ceftriaxone, and is unimproved after 72 hours of treatment. After 3 days a white mold is identified growing from his CSF culture. What medical therapy would be most appropriate now?"
        },
        {
            "id": "Pharmacology_Katzung_5118",
            "title": "Pharmacology_Katzung",
            "content": "A 45-year-old man with no significant medical history was admitted to the intensive care unit (ICU) 10 days ago after suffering third-degree burns over 40% of his body. He had been relatively stable until the last 24 hours. Now, he is febrile (39.5\u00b0C [103.1\u00b0F]), and his white blood cell count has risen from 8500 to 20,000/mm3. He has also had an episode of hypo-tension (86/50 mmHg) that responded to a fluid bolus. Blood cultures were obtained at the time of his fever and results are pending. The ICU attending physician is concerned about a bloodstream infection and decides to treat with empiric com-bination therapy directed against Pseudomonas aeruginosa. The combination therapy includes tobramycin. The patient weighs 70 kg (154 lb) and has an estimated creatinine clear-ance of 90 mL/min. How should tobramycin be dosed using once-daily and conventional dosing strategies? How should each regimen be monitored for efficacy and toxicity?"
        },
        {
            "id": "Pharmacology_Katzung_2624",
            "title": "Pharmacology_Katzung",
            "content": "Helge Eilers, MD, & Spencer Yost, MD An elderly man with type 2 diabetes mellitus and ischemic pain in the lower extremity is scheduled for femoral-to-popliteal artery bypass surgery. He has a history of hyper-tension and coronary artery disease with symptoms of stable angina. He can walk only half a block before pain in his legs forces him to stop. He has a 50-pack-year smoking history but stopped 2 years ago. Medications include atenolol, atorvastatin, and hydrochlorothiazide. The nurse in the preoperative holding area obtains the following vital signs: temperature 36.8\u00b0C (98.2\u00b0F), blood pressure 168/100 mm Hg, heart rate 78 bpm, oxygen saturation by pulse oximeter 96% while breathing room air, and pain 5/10 in the right lower leg after walking into the hospital. What anesthetic agents will you choose for his anesthetic plan? Why? Does the choice of anesthetic make a difference?"
        },
        {
            "id": "Biochemistry_Lippincott_757",
            "title": "Biochemistry_Lippinco",
            "content": "7.3. A 10-year-old boy was evaluated for burning sensations in his feet and clusters of small, red-purple spots on his skin. Laboratory studies revealed protein in his urine. Enzymatic analysis revealed a deficiency of \u03b1galactosidase, and enzyme replacement therapy was recommended. The most likely diagnosis is: A. Fabry disease. B. Farber disease. C. Gaucher disease. D. Krabbe disease. E. Niemann-Pick disease. Correct answer = A. Fabry disease, a deficiency of \u03b1-galactosidase, is the only X-linked sphingolipidosis. It is characterized by pain in the extremities, a red-purple skin rash (generalized angiokeratomas), and kidney and cardiac complications. Protein in his urine indicates kidney damage. Enzyme replacement therapy is available. 7.4. Current medical advice for individuals experiencing chest pain is to call emergency medical services and chew a regular strength, noncoated aspirin. What is the basis for recommending aspirin?"
        },
        {
            "id": "Physiology_Levy_2887",
            "title": "Physiology_Levy",
            "content": "Gastroesophageal reflux disease (GERD) is commonly referred to as heartburn or indigestion. It occurs when the lower esophageal sphincter allows the acidic contents of the stomach to reflux back into the distal part of the esophagus. This region of the esophagus, unlike the stomach, does not have a robust system to protect the mucosal lining. Thus the acid will activate pain fibers and thereby result in discomfort and pain. This is not an uncommon phenomenon, even in healthy individuals. In the long term, continual reflux can result in damage to the esophageal mucosa. In this case, this condition is classed as GERD and can be treated by H2 receptor antagonists that reduce gastric acid secretion (e.g., ranitidine [Zantac]) or by proton pump inhibitors (e.g., omeprazole [Prilosec]). The esophagus, the UES, and the lower esophageal sphincter (LES) serve two main functions ("
        },
        {
            "id": "Pharmacology_Katzung_3100",
            "title": "Pharmacology_Katzung",
            "content": "Charles DeBattista, MD * severe akathisia. Although more costly, lurasidone is then prescribed, which, over the course of several weeks of treatment, improves his symptoms and is tolerated by the patient. What signs and symptoms would support an initial diagnosis of schizophrenia? In the treatment of schizophre-nia, what benefits do the second-generation antipsychotic drugs offer over the traditional agents such as haloperidol? In addition to the management of schizophrenia, what other clinical indications warrant consideration of the use of drugs nominally classified as antipsychotics? A 19-year-old male student is brought into the clinic by his mother who has been concerned about her son\u2019s erratic behavior and strange beliefs. He destroyed a TV because he felt the TV was sending harassing messages to him. In addition, he reports hearing voices telling him that fam-ily members are trying to poison his food. As a result, he is not eating. After a diagnosis is made, haloperidol is"
        },
        {
            "id": "Biochemistry_Lippincott_1830",
            "title": "Biochemistry_Lippinco",
            "content": "Focused History: BJ reports episodes of exertional chest pain in the last few months, but they were less severe and of short duration. He smokes (2\u20133 packs per day), drinks alcohol only rarely, eats a \u201ctypical\u201d diet, and walks with his wife most weekends. His blood pressure has been normal. Family history reveals that his father and paternal aunt died of heart disease at age 45 and 39 years, respectively. His mother and younger (age 31 years) brother are said to be in good health. Physical Examination (Pertinent Findings): BJ is pale and clammy and is in distress due to chest pain. Blood pressure and respiratory rate are elevated. Lipid deposits are noted on the periphery of his corneas (corneal arcus; see left image) and under the skin on and around his eyelids (xanthelasmas; see right image). No deposits on his tendons (xanthomas) are detected."
        },
        {
            "id": "Pharmacology_Katzung_5857",
            "title": "Pharmacology_Katzung",
            "content": "Edward Chu, MD are the possible benefits of adjuvant chemotherapy? The patient receives a combination of 5-fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX) as adjuvant therapy. One week after receiving the first cycle of therapy, he experiences significant toxicity in the form of myelosup-pression, diarrhea, and altered mental status. What is the most likely explanation for this increased toxicity? Is there any role for genetic testing to determine the etiology of the increased toxicity? A 55-year-old man presents with increasing fatigue, 15-pound weight loss, and a microcytic anemia. Colonoscopy identifies a mass in the ascending colon, and biopsy specimens reveal well-differentiated colorectal cancer (CRC). He undergoes surgical resection and is found to have high-risk stage III CRC with five positive lymph nodes. After surgery, he feels entirely well with no symptoms. Of note, he has no other illnesses. What is this patient\u2019s overall prognosis? Based on his prognosis, what"
        },
        {
            "id": "Pharmacology_Katzung_4788",
            "title": "Pharmacology_Katzung",
            "content": "A 65-year-old man is referred to you from his primary care physician (PCP) for evaluation and management of pos-sible osteoporosis. He saw his PCP for evaluation of low back pain. X-rays of the spine showed some degenerative changes in the lumbar spine plus several wedge deformities in the thoracic spine. The patient is a long-time smoker (up to two packs per day) and has two to four glasses of wine with dinner, more on the weekends. He has chronic bronchitis, presumably from smoking, and has been treated on numerous occasions with oral prednisone for exacerba-tions of bronchitis. He is currently on 10 mg/d prednisone. Examination shows kyphosis of the thoracic spine, with some tenderness to fist percussion over the thoracic spine. The dual-energy x-ray absorptiometry (DEXA) measure-ment of the lumbar spine is \u201cwithin the normal limits,\u201d but the radiologist noted that the reading may be misleading because of degenerative changes. The hip measurement shows a T score (number of standard"
        },
        {
            "id": "InternalMed_Harrison_22591",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 348-12 Overview of new-onset dyspepsia. GERD, gastroesophageal reflux disease; Hp, Helicobacter pylori; IBS, irritable bowel syndrome; UBT, urea breath test. (Adapted from BS Anand and DY Graham: Endoscopy 31:215, 1999.) successful eradication. Some recommend that patients with complicated ulcer disease, or who are frail, should be treated with longterm acid suppression, thus making documentation of H. pylori eradication a moot point. In view of this discrepancy in practice, it would be best to discuss with the patient the different options available."
        },
        {
            "id": "InternalMed_Harrison_3050",
            "title": "InternalMed_Harrison",
            "content": "Upper endoscopy is recommended as the initial test in patients with unexplained dyspepsia who are >55 years old or who have alarm factors because of the purported elevated risks of malig nancy and ulcer in these groups. However, endoscopic findings in unexplained dyspepsia include erosive esophagitis in 13%, peptic ulcer in 8%, and gastric or esophageal malignancy in only 0.3%. Management of patients <55 years old without alarm factors depends on the local prevalence of H. pylori infection. In regions with low H. pylori prevalence (<10%), a 4-week trial of an acid- suppressing medication such as a proton pump inhibitor (PPI) is recommended. If this fails, a \u201ctest and treat\u201d approach is most commonly applied. H. pylori status is determined with urea breath testing, stool antigen measurement, or blood serology testing."
        },
        {
            "id": "Biochemistry_Lippincott_1903",
            "title": "Biochemistry_Lippinco",
            "content": "TQ4.Administration of folate can mask a deficiency in vitamin B12 by reversing the hematologic manifestation (macrocytic anemia) of the deficiency. However, folate has no effect on the neurologic damage caused by B12 deficiency. Over time, then, the neurologic effects can become severe and irreversible. Thus, folate can mask a deficiency of B12 and prevent treatment until the neuropathy is apparent. III. Focused Cases Case 1: Microcytic Anemia Patient Presentation: ME is a 24-year-old man who is being evaluated as a follow-up to a preplacement medical evaluation he had prior to starting his new job. Focused History: ME has no significant medical issues. His family history is unremarkable, but he knows little of the health status of those family members who remain in Greece. Pertinent Findings: The physical examination was normal. Routine analysis of his blood included the following results:"
        },
        {
            "id": "Pharmacology_Katzung_4629",
            "title": "Pharmacology_Katzung",
            "content": "A 66-year-old obese Caucasian man presented to an academic Diabetes Center for advice regarding his diabetes treatment. His diabetes was diagnosed 10 years previously on routine testing. He was initially given metformin but when his control deteriorated, the metformin was stopped and insulin treatment initiated. The patient was taking 50 units of insulin glargine and an average of 25 units of insulin aspartate pre-meals. He had never seen a diabetes educator or a dietitian. He was checking his glucose levels 4 times a day. He was smoking half a pack of cigarettes a day. On examination, his weight was 132 kg (BMI 39.5); blood pressure 145/71; and signs of mild peripheral neuropathy were present. Laboratory tests noted an HbA1c value of 8.1%, urine albumin 3007 mg/g creatinine (normal <30), serum creatinine 0.86 mg/dL (0.61\u20131.24), total choles-terol 128 mg/dL, triglycerides 86 mg/dL, HDL cholesterol 38 mg/dL, and LDL cholesterol 73 mg/dL (on atorvastatin 40 mg daily). How would you"
        }
    ],
    "scores": [
        0.02820534154255762,
        0.025018530601012858,
        0.023685515873015872,
        0.023421921657383188,
        0.022913243373333995,
        0.021211377626484534,
        0.019075302025615408,
        0.01890999910801891,
        0.01879964695498676,
        0.01837336704593342,
        0.018137254901960782,
        0.01811772421708477,
        0.017806267806267807,
        0.017745465916197627,
        0.017191142191142192,
        0.01703639263447876,
        0.016896120150187734,
        0.016835016835016835,
        0.016541865214431586,
        0.016539092400218697,
        0.01652780600149021,
        0.016464237516869096,
        0.016411084207694375,
        0.016368354514605096,
        0.01628768523249872,
        0.016167318919612497,
        0.015881577370250508,
        0.01584627862000125,
        0.015544956721427309,
        0.015495559926098098,
        0.015485739750445633,
        0.0154524089306698
    ]
}